Simplex Trading
CALT

Simplex Trading’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Simplex Trading’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$5K – 10179
2023
Q4 		$5K Buy
200
+100
+100% +$1.87K ﹤0.01% 7919
2023
Q3 		$1K Hold
100
– – ﹤0.01% 8467
2023
Q2 		$1K Hold
100
– – ﹤0.01% 8771
2023
Q1 		$2K Sell
100
-4,000
-98% -$79.9K ﹤0.01% 8575
2022
Q4 		$69K Hold
4,100
– – ﹤0.01% 5499
2022
Q3 		$62K Buy
4,100
+3,900
+1,950% +$67.9K ﹤0.01% 6149
2022
Q2 		$3K Buy
+200
New +$3.48K ﹤0.01% 9232
2022
Q1 		– Sell
-600
Closed -$14K – 11622
2021
Q4 		$14K Buy
+600
New +$12.1K ﹤0.01% 8772

Simplex Trading's CALT Position: Q4 2024 in Review

Simplex Trading sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q4 2024, closing a stake of 1,826 shares.

Simplex Trading first reported a position in CALT in Q4 2021 and held it in 9 quarters. The position peaked at $29K in Q4 2021. 0 funds tracked by Wall St. Rank hold CALT as of Q4 2024.

  • Simplex Trading reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 1,826 Calliditas Therapeutics AB American Depositary Shares shares in Q4 2024.
  • Simplex Trading first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2021 and held it in 9 quarters.
  • Simplex Trading's Calliditas Therapeutics AB American Depositary Shares position peaked at $29K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.